CD4 and relapsing-remitting multiple sclerosis: For this, we isolated total CD4+ T cells from the PBMCs of untreated patients with relapsing-remitting MS (RRMS) and of sex- and age-matched HC donors (Supplemental Table 2), and measured miR-92a by quantitative PCR (qPCR).